Grooming, scratching and feeding: role of response competition in acute anorectic response to rimonabant in male rats.
BACKGROUND
Although the CB1 receptor antagonist/inverse agonist rimonabant acutely suppresses food intake in rodents, the behavioural specificity of this effect remains unclear.


OBJECTIVE
To profile the behavioural effects of rimonabant in a free-feeding context.


METHODS
Videoanalysis was employed to characterise the effects of acute rimonabant (1.5 and 3.0 mg/kg, IP) on the behaviour of non-deprived male rats exposed to palatable mash. Data were also collected on post-treatment weight gain, and, as prolonged appetite suppression has been found after single dosing with compounds of this series, rats were reassessed (drug-free) for food intake 7 days after initial testing.


RESULTS
Both doses of rimonabant not only decreased mash consumption (44-55%) but also reduced 24-h weight gain. Although videoanalysis confirmed the inhibitory effects of rimonabant on feeding behaviour, it also revealed concurrent reductions in locomotion, rearing and sniffing as well as substantial (up to tenfold) and dose-dependent increases in grooming and scratching. Timecourse analyses further revealed that rimonabant dose-dependently induced frequent episodes of atypical scratching that waned over the test but which were succeeded by prolonged and behaviourally disruptive grooming. Finally, as groups did not differ in mash consumption on retest, any prolonged anorectic effect of acute rimonabant dissipates within 7 days of treatment.


CONCLUSIONS
The anorectic response to rimonabant in male rats would appear to be due largely to response competition. This parsimonious conclusion is supported by the less profound (although still significant) increases in scratching and grooming observed in rats treated with a sub-anorectic dose (0.5 mg/kg) of the compound.
Tallett
A J
AJ
Behavioural Neuroscience Laboratory, Institute of Psychological Sciences, University of Leeds, Leeds, UK.
Blundell
J E
JE
Rodgers
R J
RJ
D000818:Animals; D000855:Anorexia / Q000139:chemically induced / Q000503:physiopathology / Q000523:psychology*; D003627:Data Interpretation, Statistical; D004305:Dose-Response Relationship, Drug; D004435:Eating / Q000187:drug effects / Q000502:physiology / Q000523:psychology; D005247:Feeding Behavior / Q000187:drug effects* / Q000502:physiology / Q000523:psychology; D006120:Grooming / Q000187:drug effects / Q000502:physiology*; D006185:Habituation, Psychophysiologic / Q000187:drug effects; D007274:Injections, Intraperitoneal; D008297:Male; D010880:Piperidines / Q000008:administration & dosage / Q000633:toxicity*; D011537:Pruritus / Q000209:etiology / Q000523:psychology; D011720:Pyrazoles / Q000008:administration & dosage / Q000633:toxicity*; D051381:Rats; D043884:Receptor, Cannabinoid, CB1 / Q000037:antagonists & inhibitors; D012146:Rest / Q000502:physiology / Q000523:psychology; D000077285:Rimonabant; D012528:Satiety Response / Q000187:drug effects / Q000502:physiology; D013997:Time Factors; D014743:Videotape Recording / Q000379:methods; D015430:Weight Gain / Q000187:drug effects / Q000502:physiology
D010880:Piperidines; D011720:Pyrazoles; D043884:Receptor, Cannabinoid, CB1; D000077285:Rimonabant